SE431749B - Forfarande for framstellning av 14-hydroximorfinanderivat - Google Patents

Forfarande for framstellning av 14-hydroximorfinanderivat

Info

Publication number
SE431749B
SE431749B SE7703236A SE7703236A SE431749B SE 431749 B SE431749 B SE 431749B SE 7703236 A SE7703236 A SE 7703236A SE 7703236 A SE7703236 A SE 7703236A SE 431749 B SE431749 B SE 431749B
Authority
SE
Sweden
Prior art keywords
hydroximorphinand
derivative
procedure
preparation
hydroximorphinand derivative
Prior art date
Application number
SE7703236A
Other languages
English (en)
Swedish (sv)
Other versions
SE7703236L (sv
Inventor
I Monkovic
C Bachand
H Wong
G Lim
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/669,795 external-priority patent/US4058531A/en
Priority claimed from US05/769,808 external-priority patent/US4139534A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7703236L publication Critical patent/SE7703236L/xx
Publication of SE431749B publication Critical patent/SE431749B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SE7703236A 1976-03-23 1977-03-21 Forfarande for framstellning av 14-hydroximorfinanderivat SE431749B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/669,795 US4058531A (en) 1976-03-23 1976-03-23 Process for the preparation of 14-hydroxymorphinan derivatives
US05/769,808 US4139534A (en) 1977-02-17 1977-02-17 Process for the preparation of 14-hydroxymorphinan derivatives

Publications (2)

Publication Number Publication Date
SE7703236L SE7703236L (sv) 1977-09-24
SE431749B true SE431749B (sv) 1984-02-27

Family

ID=27100195

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703236A SE431749B (sv) 1976-03-23 1977-03-21 Forfarande for framstellning av 14-hydroximorfinanderivat

Country Status (8)

Country Link
JP (1) JPS52136176A (da)
CA (1) CA1086723A (da)
CH (1) CH629783A5 (da)
DK (2) DK155322C (da)
FI (1) FI61486C (da)
LU (1) LU77000A1 (da)
NL (2) NL189846C (da)
SE (1) SE431749B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0373510U (da) * 1989-11-15 1991-07-24

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634429A (en) * 1969-09-30 1972-01-11 Hoffmann La Roche Morphinan derivatives and preparation thereof
CA919668A (en) * 1970-06-20 1973-01-23 Murakami Masuo Morphinan derivatives
BE788478A (fr) * 1971-09-08 1973-03-06 Bristol Myers Co Procede de preparation de composes analgesiques
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
NL189846B (nl) 1993-03-16
LU77000A1 (da) 1977-10-03
NL960022I1 (nl) 1996-12-02
DK155322C (da) 1989-09-11
DK123877A (da) 1977-09-24
JPS52136176A (en) 1977-11-14
DK597188A (da) 1988-10-27
FI61486B (fi) 1982-04-30
JPS6139938B2 (da) 1986-09-06
CA1086723A (en) 1980-09-30
NL189846C (nl) 1993-08-16
CH629783A5 (en) 1982-05-14
NL7703000A (nl) 1977-09-27
DK597188D0 (da) 1988-10-27
FI61486C (fi) 1982-08-10
DK155322B (da) 1989-03-28
DK160987B (da) 1991-05-13
DK160987C (da) 1991-11-11
SE7703236L (sv) 1977-09-24
FI770865A (da) 1977-09-24

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7705447L (sv) Forfarande for framstellning av tioetrar

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7703236-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7703236-5

Format of ref document f/p: F